Epperly Melissa B,
CIK 1807359 · Chief Financial Officer · last filed 2026-07-21
Epperly Melissa B, is a Chief Financial Officer who has filed 57 SEC Form 4 insider transactions across 5 companies since 2020. The most recent filing, for ROIV, was dated Jul 21, 2026. Across all open-market trades the lifetime net is −$5.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.7M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.66M
5
57
-$4.97M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ROIV | Director | 17,017 | $33.88 | $576.5K | -$1.81M | 18 | 2026-07-21 |
| NAUT | Director | — | $1.20 | — | $0 | 5 | 2026-06-22 |
| ZNTL | Chief Financial Officer | 451,449 | $4.61 | $2.08M | -$3.15M | 23 | 2024-02-12 |
| Roivant Sciences Ltd. (ROIVW) Delisted | Director | 1,280 | $2.75 | $3.5K | $0 | 2 | 2023-07-06 |
| Kinnate Biopharma Inc. (KNTE) Delisted | Director | — | $2.65 | — | $0 | 3 | 2023-06-13 |
Recent Filings
57 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-07-21 | ROIV | Grant (A) | +543 | $0 | EDGAR |
| 2026-07-01 | ROIV | Mixed | — | -$531.1K | EDGAR |
| 2026-06-29 | ROIV | Notice (144) | −17,750 | -$604.7K | EDGAR |
| 2026-06-22 | NAUT | Grant (A) | — | $0 | EDGAR |
| 2026-04-21 | ROIV | Grant (A) | +670 | $0 | EDGAR |
| 2026-03-18 | ROIV | Sell (S) | −41,861 | -$1.20M | EDGAR |
| 2026-03-16 | ROIV | Notice (144) | −41,861 | -$1.20M | EDGAR |
| 2026-01-22 | ROIV | Mixed | +761 | -$1.2K | EDGAR |
| 2025-10-22 | ROIV | Grant (A) | +1,056 | $0 | EDGAR |
| 2025-09-12 | ROIV | Mixed | +12,863 | -$22.9K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.